TNF and myeloid sarcoma: IL-12 is an enhancer of the polarization of T cells to Th1 cells, a pathogenic Th subset that contributes to the progression of MS directly by damaging the myelin sheath of the oligodendrocytes and indirectly by enhancing the activation of potentially pathogenic macrophages through the secretion of TNF-α or IFN-γ37.